Obesidad abdominal: un estandarte del riesgo cardiometabólico

Yusuf, 2005, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study, Lancet, 366, 1640, 10.1016/S0140-6736(05)67663-5 Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486 Alberti, 2005, The metabolic syndrome —a new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 Despres, 2006, Is visceral obesity the cause of the metabolic syndrome?, Ann Med, 38, 52, 10.1080/07853890500383895 Salvador, 2007, The debate about metabolic syndrome: a cluster of concepts, perspectives, semantics and research, Obes Metab, 3, 1 Fernández-Real, 2003, Insulin resistance and chronic cardiovascular inflammatory syndrome, Endocr Rev, 24, 278, 10.1210/er.2002-0010 Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415 Zierath, 1998, Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway, Diabetologia, 41, 1343, 10.1007/s001250051075 Tchernof, 2006, Regional differences in adipose tissue metabolism in women. Minor effect of obesity and body fat distribution, Diabetes, 55, 1353, 10.2337/db05-1439 Mauriege, 1995, Regional variation in adipose tissue metabolism of severe obese premenopausal women, J Lipid Res, 36, 672, 10.1016/S0022-2275(20)40053-7 Wagenknecht, 2003, Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study, Diabetes, 52, 2490, 10.2337/diabetes.52.10.2490 Minokoshi, 2002, Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase, Nature, 415, 339, 10.1038/415339a Lundgren, 2004, Glucocorticoids down-regulate glucose uptake capacity and insulin- signaling proteins in omental but not subcutaneous human adipocytes, J Clin Endocrinol Metab, 89, 2989, 10.1210/jc.2003-031157 Poehlman, 1995, Changes in energy balance and body composition at menopause: a controlled longitudinal study, Ann Intern Med, 123, 673, 10.7326/0003-4819-123-9-199511010-00005 Tchernof, 2004, Ovarian hormone status and abdominal visceral adipose tissue metabolism, J Clin Endocrinol Metab, 89, 3425, 10.1210/jc.2003-031561 Pottratz, 1994, 17 beta-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism, J Clin Invest, 93, 944, 10.1172/JCI117100 Carr, 2003, The emergence of the metabolic syndrome with menopause, J Clin Endocrinol Metab, 88, 2404, 10.1210/jc.2003-030242 Bujalska, 1997, Does central obesity reflect “Cushing's disease of the omentum”?, Lancet, 349, 1210, 10.1016/S0140-6736(96)11222-8 Mauriege, 1999, Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?, J Clin Endocrinol Metab, 84, 736 Tanko, 2003, Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women, Circulation, 107, 1626, 10.1161/01.CIR.0000057974.74060.68 Pou, 2007, Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study, Circulation, 116, 1234, 10.1161/CIRCULATIONAHA.107.710509 Li, 2003, Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat, Exp Biol Med, 228, 118, 10.1177/153537020322801004 Bruun, 2003, Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans, Am J Physiol, 285, E527 Dolinkova, 2008, The endocrine profile of subcutaneous and visceral adipose tissue of obese patients, Mol Cell Endocrinol, 291, 63, 10.1016/j.mce.2008.05.001 Huber, 2008, CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity, J Clin Endocrinol Metab, 93, 3215, 10.1210/jc.2007-2630 Bluher, 2007, Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training, Diabetes Care, 30, 3110, 10.2337/dc07-1257 Von Eyben, 2004, Comparison of gene expression in intra-abdominal and subcutaneous fat. A study of men with morbid obesity and nonobese men using microarray and proteomics, Ann N Y Acad Sci, 1030, 508, 10.1196/annals.1329.063 Ohashi, 2004, Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease, J Am Coll Cardiol, 43, 1195, 10.1016/j.jacc.2003.10.049 Rosmond, 2002, The glucocorticoid receptor gene and its association to metabolic syndrome, Obes Res, 10, 1078, 10.1038/oby.2002.146 Laye, 2007, Inactivity induces increases in abdominal fat, J Appl Physiol, 102, 1341, 10.1152/japplphysiol.01018.2006 Regitz-Zagrosek, 2006, Gender differences in the metabolic syndrome and their role for cardiovascular disease, Clin Res Cardiol, 95, 136, 10.1007/s00392-006-0351-5 Weinberg, 2006, Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women, Metabolism, 55, 1473, 10.1016/j.metabol.2006.06.017 Glueck, 2003, Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome, Metabolism, 52, 908, 10.1016/S0026-0495(03)00104-5 Van der Klaauw, 2007, The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH, Eur J Endocrinol, 156, 455, 10.1530/EJE-06-0699 Pasquali, 2000, Activity of the hypothalamic-pituitary- adrenal axis in different obesity phenotypes, Int J Obes Relat Metab Disord, 24, S47, 10.1038/sj.ijo.0801277 Desbriere, 2006, 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients, Obesity, 14, 794, 10.1038/oby.2006.92 Branth, 2007, Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress, Nutr Metab Cardiovasc Dis, 17, 427, 10.1016/j.numecd.2006.03.001 Kyrou, 2006, Stress, visceral obesity, and metabolic complications, Ann N Y Acad Sci, 1083, 77, 10.1196/annals.1367.008 Engeli, 2006, The endocannabinoid system: body weight and metabolic regulation, Clin Cornerstone, 8, S24, 10.1016/S1098-3597(06)80041-4 Williams, 2002, Observational analysis of feeding induced by delta 9-THC and anandamide, Physiol Behav, 76, 241, 10.1016/S0031-9384(02)00725-4 Bensaid, 2003, The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells, Mol Pharmacol, 63, 908, 10.1124/mol.63.4.908 Osei-Hyiaman, 2005, Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to dietinduced obesity, J Clin Invest, 115, 1298, 10.1172/JCI200523057 Liu, 2005, Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice, Int J Obes, 29, 183, 10.1038/sj.ijo.0802847 Engeli, 2005, Activation of the peripheral endocannabinoid system in human obesity, Diabetes, 54, 2838, 10.2337/diabetes.54.10.2838 Rahmouni, 2004, Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity, Am J Physiol Endocrinol Metab, 286, E891, 10.1152/ajpendo.00551.2003 Amador, 2004, Sympathetic activity and response to ACE inhibitor (enalapril) in normotensive obese and non-obese subjects, Arch Med Res, 35, 54, 10.1016/j.arcmed.2003.08.010 Ryan, 2004, Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women, Diabetes Care, 27, 1699, 10.2337/diacare.27.7.1699 Iacobellis, 2005, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart, Nature Clin Pract Cardiovasc Med, 2, 536, 10.1038/ncpcardio0319 Sacks, 2007, Human epicardial adipose tissue: a review, Am Heart J, 153, 907, 10.1016/j.ahj.2007.03.019 Iacobellis, 2008, Threshold values of high-risk echocardiographic epicardial fat thickness, Obesity, 16, 887, 10.1038/oby.2008.6 Fruhbeck, 2004, Role of adipocytokines in metabolism and disease, Nutr Res, 24, 803, 10.1016/j.nutres.2004.07.002 Fruhbeck, 2001, The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation, Am J Physiol Endocrinol Metab, 280, E827, 10.1152/ajpendo.2001.280.6.E827 Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514 Neels, 2006, Inflammed fat: what starts the fire?, J Clin Invest, 16, 33 Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, 116, 1494, 10.1172/JCI26498 Pradhan, 2001, Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767 Senn, 2003, Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes, J Biol Chem, 278, 13740, 10.1074/jbc.M210689200 Boden, 2002, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction, Eur J Clin Invest, 32, 14, 10.1046/j.1365-2362.32.s3.3.x Fasshauer, 2003, Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes, Biochem Biophys Res Commun, 301, 1045, 10.1016/S0006-291X(03)00090-1 Hotamisligil, 1994, Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diab.43.11.1271 Dzienis-Straczkowska, 2003, Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance, Diabetes Care, 26, 875, 10.2337/diacare.26.3.875 Bruun, 2003, Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans, Am J Physiol Endocrinol Metab, 285, E527, 10.1152/ajpendo.00110.2003 Lyon, 2003, Minireview: adiposity, inflammation, and atherogenesis, Endocrinology, 144, 2195, 10.1210/en.2003-0285 Zinman, 1999, Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus, J Clin Endocrinol Metab, 84, 272 Bullo, 2003, Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression, Obes Res, 11, 525, 10.1038/oby.2003.74 Pasceri, 2000, Direct proinflammatory effect of C-reactive protein on human endothelial cells, Circulation, 102, 2165, 10.1161/01.CIR.102.18.2165 Szmitko, 2003, New markers of inflammation and endothelial cell activation: Part I, Circulation, 108, 1917, 10.1161/01.CIR.0000089190.95415.9F Kadowaki, 2006, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest, 116, 1784, 10.1172/JCI29126 Matsushita, 2006, Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men, Arterioscler Thromb Vasc Biol, 26, 871, 10.1161/01.ATV.0000208363.85388.8f Matsuzawa, 2006, Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease, Nature Clin Pract Cardiovasc Med, 3, 35, 10.1038/ncpcardio0380 Halleux, 2001, Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue, Biochem Biophys Res Commun, 288, 1102, 10.1006/bbrc.2001.5904 Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724 Lindsay, 2002, Adiponectin and development of type 2 diabetes in the Pima Indian population, Lancet, 360, 57, 10.1016/S0140-6736(02)09335-2 Szmitko, 2007, Adiponectin and cardiovascular disease: state of the art?, Am J Physiol Heart Circ Physiol, 292, H1655, 10.1152/ajpheart.01072.2006 Ouchi, 2003, Association of hypoadiponectinemia with impaired vasoreactivity, Hypertension, 42, 231, 10.1161/01.HYP.0000083488.67550.B8 Iwashima, 2004, Hypoadiponectinemia is an independent risk factor for hypertension, Hypertension, 43, 1318, 10.1161/01.HYP.0000129281.03801.4b Ouchi, 2000, Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMPdependent pathway, Circulation, 102, 1296, 10.1161/01.CIR.102.11.1296 Arita, 2002, Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell, Circulation, 105, 2893, 10.1161/01.CIR.0000018622.84402.FF Berndt, 2005, Plasma visfatin concentrations and fat depotspecific mRNA expression in humans, Diabetes, 54, 2911, 10.2337/diabetes.54.10.2911 Moschen, 2007, Visfatin, an adipocytokine with proinflammatory and immunomodulating properties, J Immunol, 178, 1748, 10.4049/jimmunol.178.3.1748 Harle, 2006, Leptin is a link between adipose tissue and inflammation, Ann N Y Acad Sci, 1069, 454, 10.1196/annals.1351.044 Gomez-Ambrosi, 2006, Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin, Thromb Haemost, 95, 991, 10.1160/TH06-02-0079 Fain, 2003, Resistin release by human adipose tissue explants in primary culture, Biochem Biophys Res Commun, 300, 674, 10.1016/S0006-291X(02)02864-4 Steppan, 2001, The hormone resistin links obesity to diabetes, Nature, 409, 307, 10.1038/35053000 Kunnari, 2006, High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes, J Clin Endocrinol Metab, 91, 2755, 10.1210/jc.2005-2115 Aquilante, 2008, Relationship between plasma resistin concentrations, inflammatory chemokines and components of the metabolic syndrome in adults, Metabolism, 57, 494, 10.1016/j.metabol.2007.11.010 Alessi, 2006, PAI-1 and the metabolic syndrome: links, causes, and consequences, Arterioscler Thromb Vasc Biol, 26, 2200, 10.1161/01.ATV.0000242905.41404.68 Ziccardi, 2002, Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year, Circulation, 105, 804, 10.1161/hc0702.104279 Bosch, 2005, Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass, Diabetologia, 48, 1841, 10.1007/s00125-005-1859-3 Heeschen, 2003, Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes, Circulation, 107, 2109, 10.1161/01.CIR.0000065232.57371.25 Yang, 2006, Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action, Am J Physiol Endocrinol Metab, 290, E1253, 10.1152/ajpendo.00572.2004 Zhang, 2008, The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages, Mol Endocrinol, 10.1210/me.2007-0420 Gómez-Ambrosi, 2008, Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass, Clin Endocrinol, 69, 208, 10.1111/j.1365-2265.2007.03156.x Catalán, 2008, Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation, Clin Endocrinol, 68, 213 Rebuffe-Scrive, 1989, Metabolism of adipose tissue in intraabdominal depots of nonobese men and women, Metabolism, 38, 453, 10.1016/0026-0495(89)90198-4 Nielsen, 2004, Splanchnic lipolysis in human obesity, J Clin Invest, 113, 1582, 10.1172/JCI21047 Skilton, 2006, Endothelial dysfunction and arterial abnormalities in childhood obesity, Int J Obes, 30, 1041, 10.1038/sj.ijo.0803397 Glowinska, 2005, Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes, Metabolism, 54, 1020, 10.1016/j.metabol.2005.03.004 Furukawa, 2004, Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, 114, 1752, 10.1172/JCI21625 Sonnenberg, 2004, A novel pathway to the manifestations of metabolic syndrome, Obes Res, 12, 180, 10.1038/oby.2004.24 Janssen, 2004, Waist circumference and not body mass index explains obesity-related health risk, Am J Clin Nutr, 79, 379, 10.1093/ajcn/79.3.379 Bigaard, 2005, Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women, Int J Obes, 29, 778, 10.1038/sj.ijo.0802976 Hu, 2004, Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women, Arch Int Med, 164, 1066, 10.1001/archinte.164.10.1066 Kuk, 2006, Visceral fat is an independent predictor of allcause mortality in men, Obesity, 14, 336, 10.1038/oby.2006.43 Fuster, 2005, Obesity: a challenge for science and society, Nature Clin Pract, 2, 1 Gami, 2007, Metabolic syndrome and risk of incident cardiovascular events and death, J Am Coll Cardiol, 49, 403, 10.1016/j.jacc.2006.09.032 Chuang, 2006, Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension, Am J Hypertens, 19, 788, 10.1016/j.amjhyper.2006.01.010 Gomez-Ambrosi, 2007, Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass, Obes Surg, 17, 585, 10.1007/s11695-007-9101-7 Balkau, 2007, International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries, Circulation, 116, 1942, 10.1161/CIRCULATIONAHA.106.676379 McCullough, 2006, Pathophysiology of non-alcoholic steatohepatitis, J Clin Gastroenterol, 40, S17 Hanley, 2005, Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study, Diabetes, 54, 3140, 10.2337/diabetes.54.11.3140 Targher, 2006, Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease, Clin Endocrinol (Oxf), 64, 679, 10.1111/j.1365-2265.2006.02527.x Sharma, 2004, Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart, FASEB J, 18, 1692, 10.1096/fj.04-2263com Willens, 2005, Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging, Am J Cardiol, 95, 1521, 10.1016/j.amjcard.2005.02.029 Hsing, 2007, Obesity, metabolic syndrome, and prostate cancer, Am J Clin Nutr, 86, S843, 10.1093/ajcn/86.3.843S Giovannucci, 2007, Metabolic syndrome, hyperinsulinemia, and colon cancer: a review, Am J Clin Nutr, 86, S836, 10.1093/ajcn/86.3.836S Pasquali, 2006, Obesity, fat distribution and infertility, Maturitas, 54, 363, 10.1016/j.maturitas.2006.04.018 Ruderman, 1981, The “metabolically-obese”, normal-weight individual, Am J Clin Nutr, 34, 1617, 10.1093/ajcn/34.8.1617 Karelis, 2004, Metabolic and body composition factors in subgroups of obesity: what do we know?, J Clin Endocrinol Metab, 89, 2569, 10.1210/jc.2004-0165 Wong, 2004, Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index, Med Sci Sports Exerc, 36, 286, 10.1249/01.MSS.0000113665.40775.35 Thorne, 2002, A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding, Int J Obes Relat Metab Disord, 26, 193, 10.1038/sj.ijo.0801871 Eckel, 2006, Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association, Diabetes Care, 29, 1697, 10.2337/dc06-9911 Despres, 2006, Abdominal obesity and metabolic syndrome, Nature, 444, 881, 10.1038/nature05488 Hunt, 2004, National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study, Circulation, 110, 1251, 10.1161/01.CIR.0000140762.04598.F9 Klein, 2007, Am J Clin Nutr, 85, 1197, 10.1093/ajcn/85.5.1197